ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mars 2024 (2024)

ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mars 2024

Regulatory News:

Conformément aux dispositions de l’article L.233-8 II du Code deCommerce et de l’article 223-16 du Règlement Général de l’Autoritédes Marchés Financiers (« AMF »). ADOCIA SA (Paris:ADOC), 115,avenue Lacassagne, 69003 Lyon (Euronext Paris : FR0011184241 – ADOC– la « Société »), société biopharmaceutique au stade cliniquespécialisée dans la recherche et le développement de solutionsthérapeutiques innovantes pour le traitement du diabète et del’obésité publie le nombre d’actions composant son capital socialainsi que le nombre de droits de vote associés au 31 mars 2024.

Mois

Date

Nombre d’actions composant lecapital

Nombre de droits de vote BRUT(1)

Nombre de droits de vote NET(2)

Mars

31/03/2024

14 298 513*

16 426 056

16 419 211

* Aucune action nouvelle n’a été émise dans le cadre de laligne de financement PACEO dont les caractéristiques sont décritesdans notre communiqué de presse du 21 mars 2024.

(1) Le nombre de droits de vote théoriques (ou droits de vote« bruts ») sert de base de calcul pour les franchissem*nts deseuils. Conformément à l’article 223-11 du Règlement Général del’AMF, ce nombre est calculé sur la base de l’ensemble des actionsauxquelles sont attachés des droits de vote, y compris les actionsprivées de droit de vote.

(2) Le nombre de droits de vote exerçables (ou droits de vote« nets ») est calculé en ne tenant pas compte des actionsauto-détenues par la Société, privées de droit de vote. Il estcommuniqué pour la bonne information du public, conformément à larecommandation de l’AMF du 17 juillet 2007.

A propos d’Adocia

Adocia est une société de biotechnologie spécialisée dans ladécouverte et le développement de solutions thérapeutiques dans ledomaine des maladies métaboliques, principalement le diabète etl’obésité.

La société dispose d’un large portefeuille decandidats-médicaments issus de quatre plateformes technologiquespropriétaires :

1) Une technologie, BioChaperone®, pour ledéveloppement d’insulines de nouvelle génération et de combinaisonsassociant des insulines à d’autres familles d’hormones ; 2)AdOral®, une technologie de délivrance orale de peptides; 3) AdoShell®, un biomatériau synthétiqueimmunoprotecteur pour la greffe de cellules, avec une premièreapplication aux cellules pancréatiques et 4) AdoGel®,pour la libération longue durée d’agents thérapeutiques.
Adocia détient plus de 25 familles de brevets. Installée à Lyon,l’entreprise compte environ 80 collaborateurs. Adocia est unesociété cotée sur le marché EuronextTM Paris (Euronext :ADOC ; ISIN : FR0011184241).

Avertissem*nt

Le présent communiqué contient des déclarations prospectivesrelatives à Adocia et à ses activités. Adocia estime que cesdéclarations prospectives reposent sur des hypothèses raisonnables.Cependant, aucune garantie ne peut être donnée quant à laréalisation des prévisions exprimées dans ces déclarationsprospectives qui sont soumises à des risques dont ceux décrits dansle document d’enregistrement universel d’Adocia déposé auprès del’Autorité des marchés financiers le 26 avril 2023, tels que mis àjour par l’amendement du 26 juillet 2023 (D.23-0346-A01) etl’amendement du 13 septembre 2023 (D.23-0346-A02) et disponiblessur le site Internet d’Adocia (www.adocia.com), etnotamment aux incertitudes inhérentes à la recherche etdéveloppement, aux futures données cliniques et analyses et àl’évolution de la conjoncture économique, des marchés financiers etdes marchés sur lesquels Adocia est présente qui pourraientimpacter les besoins de financement à court terme de laSociété et à sa capacité de lever des fondssupplémentaires.
Les déclarations prospectives figurantdans le présent communiqué sont également soumises à des risquesinconnus d’Adocia ou qu’Adocia ne considère pas comme significatifsà cette date.
La réalisation de tout ou partie de cesrisques pourrait conduire à ce que les résultats réels, conditionsfinancières, performances ou réalisations d’Adocia diffèrentsignificativement des résultats, conditions financières,performances ou réalisations exprimés dans cesdéclarations.
Le présent communiqué et les informationsqu’il contient ne constituent ni une offre de vente ou desouscription, ni la sollicitation d’un ordre d’achat ou desouscription des actions d’Adocia dans un quelconque pays.

ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mars 2024 (1)

Consultez laversion source sur businesswire.com: https://www.businesswire.com/news/home/20240412793825/fr/

Adocia
Olivier Soula
Directeur Général
contactinvestisseurs@adocia.com
+33 4 72 610 610
www.adocia.com

Ulysse Communication
Adocia Relations Presse et investisseurs
Bruno Arabian
Nicolas Entz
adocia@ulysse-communication.com
+ 33 (0)6 87 88 47 26

Edoc Acquisition (NASDAQ:ADOC)
Historical Stock Chart
From Mar 2024 to Apr 2024

Edoc Acquisition (NASDAQ:ADOC)
Historical Stock Chart
From Apr 2023 to Apr 2024

ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mars 2024 (4){{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}}
  • Share on Facebook Share on Twitter Share on Email

Loading Messages....

No posts yet, be the first!No ADOC Message Board. Create One!See More Posts on ADOC Message BoardSee More Message Board Posts

Edoc Acquisition Corporation News

Loading Messages....

`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `

`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `

No News, be the first to add your company releases.

`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjE4NA==","timestamp":1713268369,"date":"Tue Apr 16, 2024 ","time":"7:52 AM (4 hours ago)","isPromoted":true},{"headline":"Number of Shares and Voting Rights of ADOCIA as of March 31st, 2024","short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French stock-market authorities (Autorit\u00e9 des March\u00e9s Financiers...","one_line_short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93644008\/number-of-shares-and-voting-rights-of-adocia-as-of","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1712937600,"date":"Fri Apr 12, 2024 ","time":"12:00 PM (4 days ago)","full_date":"April 12, 2024 12:00 PM","post_time":"April 12 2024","article_id":93644008,"source_id":"bw","media_url":null,"press_release":true},{"headline":"ADOCIA annonce une lev\u00e9e de fonds de 2 millions d\u2019euros aupr\u00e8s de ses deux actionnaires principaux et un membre de sa Direction, ainsi que la signature d\u2019une ligne de financement en fonds propres avec Vester Finance","short_text":"\n\nUne lev\u00e9e de fonds pour un montant de 2 millions d\u2019euros au b\u00e9n\u00e9fice de : G\u00e9rard Soula, Pr\u00e9sident du Conseil d\u2019Administration, Olivier Soula, Directeur G\u00e9n\u00e9ral, co-fondateurs, ainsi qu\u2019un membre...","one_line_short_text":"\n\nUne lev\u00e9e de fonds pour un montant de 2 millions d\u2019euros au b\u00e9n\u00e9fice de : G\u00e9rard Soula, Pr\u00e9sident du Conseil d\u2019Administration, Olivier Soula...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93531401\/adocia-annonce-une-levee-de-fonds-de-2-millions-d","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1711053600,"date":"Thu Mar 21, 2024 ","time":"4:40 PM (4 weeks ago)","full_date":"March 21, 2024 4:40 PM","post_time":"March 21 2024","article_id":93531401,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Number of Shares and Voting Rights of Adocia as of February 29th, 2024","short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French stock-market authorities (Autorit\u00e9 des March\u00e9s Financiers...","one_line_short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93498207\/number-of-shares-and-voting-rights-of-adocia-as-of","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1710522000,"date":"Fri Mar 15, 2024 ","time":"1:00 PM (1 month ago)","full_date":"March 15, 2024 1:00 PM","post_time":"March 15 2024","article_id":93498207,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93467694\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1710190847,"date":"Mon Mar 11, 2024 ","time":"5:00 PM (1 month ago)","full_date":"March 11, 2024 5:00 PM","post_time":"March 11 2024","article_id":93467694,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 425 - Prospectuses and communications, business combinations","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93447656\/form-425-prospectuses-and-communications-busine","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709845147,"date":"Thu Mar 07, 2024 ","time":"3:59 PM (1 month ago)","full_date":"March 7, 2024 3:59 PM","post_time":"March 07 2024","article_id":93447656,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"ADOCIA Announces Its Participation at Key Events","short_text":"\nRegulatory News: Adocia (Euronext Paris: FR0011184241 \u2013 ADOC), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the...","one_line_short_text":"\nRegulatory News: Adocia (Euronext Paris: FR0011184241 \u2013 ADOC), a clinical-stage biopharmaceutical Company focused on the research and development...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93436917\/adocia-announces-its-participation-at-key-events","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1709744400,"date":"Wed Mar 06, 2024 ","time":"12:00 PM (1 month ago)","full_date":"March 6, 2024 12:00 PM","post_time":"March 06 2024","article_id":93436917,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Form 425 - Prospectuses and communications, business combinations","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93405544\/form-425-prospectuses-and-communications-busine","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709331888,"date":"Fri Mar 01, 2024 ","time":"5:24 PM (2 months ago)","full_date":"March 1, 2024 5:24 PM","post_time":"March 01 2024","article_id":93405544,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93405525\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709331774,"date":"Fri Mar 01, 2024 ","time":"5:22 PM (2 months ago)","full_date":"March 1, 2024 5:22 PM","post_time":"March 01 2024","article_id":93405525,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination","short_text":"Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (\u201cEDOC\u201d) announced today that it has postponed its extraordinary general meeting of its shareholders (the...","one_line_short_text":"Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (\u201cEDOC\u201d) announced today that it has postponed its...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93372334\/edoc-acquisition-corp-announces-postponement-of-s","source":"GlobeNewswire Inc.","source_logo":"\/common\/images\/news-sources\/globe.png","tags":[],"timestamp":1709073130,"date":"Tue Feb 27, 2024 ","time":"5:32 PM (2 months ago)","full_date":"February 27, 2024 5:32 PM","post_time":"February 27 2024","article_id":93372334,"source_id":"globe","media_url":null,"press_release":true},{"headline":"Form 425 - Prospectuses and communications, business combinations","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93372318\/form-425-prospectuses-and-communications-busine","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709072989,"date":"Tue Feb 27, 2024 ","time":"5:29 PM (2 months ago)","full_date":"February 27, 2024 5:29 PM","post_time":"February 27 2024","article_id":93372318,"source_id":"edgar2","media_url":null,"press_release":true}],"All News": [{"headline":"Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjE4NA==","timestamp":1713268369,"date":"Tue Apr 16, 2024 ","time":"7:52 AM (4 hours ago)","isPromoted":true},{"headline":"Number of Shares and Voting Rights of ADOCIA as of March 31st, 2024","short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French stock-market authorities (Autorit\u00e9 des March\u00e9s Financiers...","one_line_short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93644008\/number-of-shares-and-voting-rights-of-adocia-as-of","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1712937600,"date":"Fri Apr 12, 2024 ","time":"12:00 PM (4 days ago)","full_date":"April 12, 2024 12:00 PM","post_time":"April 12 2024","article_id":93644008,"source_id":"bw","media_url":null,"press_release":true},{"headline":"ADOCIA annonce une lev\u00e9e de fonds de 2 millions d\u2019euros aupr\u00e8s de ses deux actionnaires principaux et un membre de sa Direction, ainsi que la signature d\u2019une ligne de financement en fonds propres avec Vester Finance","short_text":"\n\nUne lev\u00e9e de fonds pour un montant de 2 millions d\u2019euros au b\u00e9n\u00e9fice de : G\u00e9rard Soula, Pr\u00e9sident du Conseil d\u2019Administration, Olivier Soula, Directeur G\u00e9n\u00e9ral, co-fondateurs, ainsi qu\u2019un membre...","one_line_short_text":"\n\nUne lev\u00e9e de fonds pour un montant de 2 millions d\u2019euros au b\u00e9n\u00e9fice de : G\u00e9rard Soula, Pr\u00e9sident du Conseil d\u2019Administration, Olivier Soula...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93531401\/adocia-annonce-une-levee-de-fonds-de-2-millions-d","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1711053600,"date":"Thu Mar 21, 2024 ","time":"4:40 PM (4 weeks ago)","full_date":"March 21, 2024 4:40 PM","post_time":"March 21 2024","article_id":93531401,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Number of Shares and Voting Rights of Adocia as of February 29th, 2024","short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French stock-market authorities (Autorit\u00e9 des March\u00e9s Financiers...","one_line_short_text":"\nRegulatory News: Pursuant to the provisions of article L. 233-8 II of the French \u00ab Code de Commerce \u00bb and article 223-16 of the French...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93498207\/number-of-shares-and-voting-rights-of-adocia-as-of","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1710522000,"date":"Fri Mar 15, 2024 ","time":"1:00 PM (1 month ago)","full_date":"March 15, 2024 1:00 PM","post_time":"March 15 2024","article_id":93498207,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93467694\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1710190847,"date":"Mon Mar 11, 2024 ","time":"5:00 PM (1 month ago)","full_date":"March 11, 2024 5:00 PM","post_time":"March 11 2024","article_id":93467694,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 425 - Prospectuses and communications, business combinations","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93447656\/form-425-prospectuses-and-communications-busine","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709845147,"date":"Thu Mar 07, 2024 ","time":"3:59 PM (1 month ago)","full_date":"March 7, 2024 3:59 PM","post_time":"March 07 2024","article_id":93447656,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"ADOCIA Announces Its Participation at Key Events","short_text":"\nRegulatory News: Adocia (Euronext Paris: FR0011184241 \u2013 ADOC), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the...","one_line_short_text":"\nRegulatory News: Adocia (Euronext Paris: FR0011184241 \u2013 ADOC), a clinical-stage biopharmaceutical Company focused on the research and development...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93436917\/adocia-announces-its-participation-at-key-events","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1709744400,"date":"Wed Mar 06, 2024 ","time":"12:00 PM (1 month ago)","full_date":"March 6, 2024 12:00 PM","post_time":"March 06 2024","article_id":93436917,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Form 425 - Prospectuses and communications, business combinations","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93405544\/form-425-prospectuses-and-communications-busine","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709331888,"date":"Fri Mar 01, 2024 ","time":"5:24 PM (2 months ago)","full_date":"March 1, 2024 5:24 PM","post_time":"March 01 2024","article_id":93405544,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93405525\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709331774,"date":"Fri Mar 01, 2024 ","time":"5:22 PM (2 months ago)","full_date":"March 1, 2024 5:22 PM","post_time":"March 01 2024","article_id":93405525,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination","short_text":"Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (\u201cEDOC\u201d) announced today that it has postponed its extraordinary general meeting of its shareholders (the...","one_line_short_text":"Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (\u201cEDOC\u201d) announced today that it has postponed its...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93372334\/edoc-acquisition-corp-announces-postponement-of-s","source":"GlobeNewswire Inc.","source_logo":"\/common\/images\/news-sources\/globe.png","tags":[],"timestamp":1709073130,"date":"Tue Feb 27, 2024 ","time":"5:32 PM (2 months ago)","full_date":"February 27, 2024 5:32 PM","post_time":"February 27 2024","article_id":93372334,"source_id":"globe","media_url":null,"press_release":true},{"headline":"Form 425 - Prospectuses and communications, business combinations","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/edoc-acquisition-ADOC\/stock-news\/93372318\/form-425-prospectuses-and-communications-busine","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1709072989,"date":"Tue Feb 27, 2024 ","time":"5:29 PM (2 months ago)","full_date":"February 27, 2024 5:29 PM","post_time":"February 27 2024","article_id":93372318,"source_id":"edgar2","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});

More Edoc Acquisition Corporation News Articles

ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mars 2024 (2024)
Top Articles
Latest Posts
Article information

Author: Trent Wehner

Last Updated:

Views: 5825

Rating: 4.6 / 5 (76 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Trent Wehner

Birthday: 1993-03-14

Address: 872 Kevin Squares, New Codyville, AK 01785-0416

Phone: +18698800304764

Job: Senior Farming Developer

Hobby: Paintball, Calligraphy, Hunting, Flying disc, Lapidary, Rafting, Inline skating

Introduction: My name is Trent Wehner, I am a talented, brainy, zealous, light, funny, gleaming, attractive person who loves writing and wants to share my knowledge and understanding with you.